Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


BIOMERIEUX S.A.

Marcy L'Etoile, FR

BIOMERIEUX S.A. Patent applications
Patent application numberTitlePublished
20120129204NOVEL NITROREDUCTASE ENZYMATIC SUBSTRATES - The invention relates to the use of a compound having formula (I) as an enzymatic substrate for the detection of a nitroreductase activity, wherein: W05-24-2012
20120129203Novel Peptidase Substrates - The present invention relates to the use of a compound of the following formula (I) for detecting a peptidase activity and/or a variation in pH:05-24-2012
20120122148Media For The Specific Detection Of Gram-Negative Bacteria Resistant To Beta-Lactam Antibiotics - The invention relates to a reaction medium for gram-negative bacteria having a beta-lactam antibiotic resistance mechanism, comprising: 05-17-2012
20120122135Novel Peptidase Substrates - The present invention relates to the use of a compound of the following formula (I), as an enzyme substrate for the detection of a peptidase activity or as a pH indicator:05-17-2012
20120122134Novel Peptidase Substrates - The present invention relates to the use of a compound of the following formula (I) for detecting a peptidase activity and/or a variation in pH:05-17-2012
20120046188Solid Support for HCV Detection - The present invention relates to a solid support for an immunological test for the detection of HCV, to which the following are attached: 02-23-2012
20110275110METHOD FOR ISOLATING OR COUNTING MICROORGANISMS ON AN AGAR CULTURE MEDIUM - The invention relates to a method for isolating microorganisms on an agar culture medium, including the steps of: 11-10-2011
20100062540Method for Detecting Aggregate-Forming Circulating Protein Forms Using an Agent for Aggregating Said Forms and an Agent for Capturing Formed Aggregates - The present invention concerns a method for detecting aggregate-forming circulating protein forms in a biological sample of human origin that may contain said aggregate-forming circulating protein forms, characterized in that it uses a non-protein agent I producing aggregation of the circulating forms of the noninfectious proteins involved in pathological aggregation processes of the central nervous system and/or a non-protein agent II for capturing the natural aggregrates of aggregate-forming circulating protein forms or the aggregates induced by said agents I.03-11-2010
20100047895Methods for purification of bacterial cells and cell components - The present invention relates to a method for the selective purification of bacterial cells and/or cell components, whereby the purification is performed by means of a solid support.02-25-2010
20100041038METHOD FOR DISCRIMINATING SINGLE NUCLEOTIDE POLYMORPHISMS - A method for discriminating single nucleotide polymorphisms (SNPs) offers improved sensitivity and specificity. A test kit is also provided. The method may be for genotyping in typing assays applied to a biological sample. The method may include steps of performing a real-time amplification of the target, generating multiple copies of amplicons, in presence of at least two different labeled probes, each probe allowing real-time detection at the SNP position of both the wildtype and at least one possible mutation, assessing the discriminatory variable value(s) based on the signals of each combination of two detection probes, and discriminating between the genotypes. The methods may be for diagnostic, preventive and therapeutic applications.02-18-2010
20090269744CANCER DETECTION METHOD - The present application concerns methods and compositions which can be used to detect cancer in mammals, in particular in humans. It notably describes serum markers of cancers and their uses in diagnosis methods. It also concerns tools and/or kits which can be used to implement these methods (reagents, probes, primers, antibodies, chips, cells, etc.), their preparation and their uses. The invention can be used to detect the presence or the progression of a cancer, particularly breast cancer, including at an early stage.10-29-2009
20090186023ANTIBODIES DIRECTED AGAINST HEPATITIS C VIRUS E1E2 COMPLEX, COMPOSITIONS OF HCV PARTICLES, AND PHARMACEUTICAL COMPOSITIONS - New conformational antibodies are directed against HCV and more particularly to monoclonal antibodies. Described compositions of particles are liable to be recognized by the antibodies, as are pharmaceutical compositions containing them. Also described are HCV enveloped subviral particles or purified HCV enveloped complete viral particles, and the processes for preparing them.07-23-2009
20090047659AMPLIFICATION OF HIV-1 SEQUENCES FOR DETECTION OF SEQUENCES ASSOCIATED WITH DRUG-RESISTANCE MUTATIONS - Sequences of nucleic acid oligonucleotides for amplifying different portions of gag and pol genes of HIV-1 and for detecting such amplified nucleic acid sequences are disclosed. Methods of amplifying and detecting HIV-1 nucleic acid in a biological sample using the amplification oligonucleotides specific for gag and pol target sequences are disclosed.02-19-2009
20090029360Nucleic Acid Amplification and Detection of Mycobacterium Species - Oligonucleotides used to prime in vitro nucleic acid amplification of 16S rRNA sequences or DNA encoding 16S rRNA sequences for many species within the genus 01-29-2009
20090013768DEVICE FOR BIOASSAYS WITH INTEGRATED DETECTOR - The disclosure relates to a biological analysis device including: 01-15-2009
20080290321Fluorescent Polymers Soluble in an Aqueous Solution and a Method for the Production Thereof - The invention relates to fluorescent polymers soluble in an aqueous solution carrying at least 5 fluorophores which are distributed on the polymer and which exhibit the following properties: 11-27-2008

Patent applications by BIOMERIEUX S.A.